News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OvaScience (OVAS)’s Eggpc Technology Recognized By Science As A Top Ten Advancement In Reproductive Medicine


1/8/2014 9:55:42 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Science magazine has named OvaScience’s egg precursor cell (EggPCSM) technology, as described in the March 2012 Nature Medicine publication, one of the top ten papers in reproductive medicine. The publication challenged the existing paradigm that women are born with a set number of eggs, and demonstrated for the first time that EggPCs found on the ovaries can be matured into young, healthy eggs. The article by OvaScience co-founder, Jonathan Tilly, Ph.D., was recognized as part of a December 2013 supplement in Science.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES